1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global COVID-19 Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Tablet 1.2.3 Injection 1.3 Market by Application 1.3.1 Global COVID-19 Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Mild Symptom Patient 1.3.3 Critically Ill Patient 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global COVID-19 Drugs Market Perspective (2018-2029) 2.2 Global COVID-19 Drugs Growth Trends by Region 2.2.1 COVID-19 Drugs Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 COVID-19 Drugs Historic Market Size by Region (2018-2023) 2.2.3 COVID-19 Drugs Forecasted Market Size by Region (2024-2029) 2.3 COVID-19 Drugs Market Dynamics 2.3.1 COVID-19 Drugs Industry Trends 2.3.2 COVID-19 Drugs Market Drivers 2.3.3 COVID-19 Drugs Market Challenges 2.3.4 COVID-19 Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue COVID-19 Drugs by Players 3.1.1 Global COVID-19 Drugs Revenue by Players (2018-2023) 3.1.2 Global COVID-19 Drugs Revenue Market Share by Players (2018-2023) 3.2 Global COVID-19 Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of COVID-19 Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global COVID-19 Drugs Market Concentration Ratio 3.4.1 Global COVID-19 Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Drugs Revenue in 2022 3.5 Global Key Players of COVID-19 Drugs Head office and Area Served 3.6 Global Key Players of COVID-19 Drugs, Product and Application 3.7 Global Key Players of COVID-19 Drugs, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 COVID-19 Drugs Breakdown Data by Type 4.1 Global COVID-19 Drugs Historic Market Size by Type (2018-2023) 4.2 Global COVID-19 Drugs Forecasted Market Size by Type (2024-2029) 5 COVID-19 Drugs Breakdown Data by Application 5.1 Global COVID-19 Drugs Historic Market Size by Application (2018-2023) 5.2 Global COVID-19 Drugs Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America COVID-19 Drugs Market Size (2018-2029) 6.2 North America COVID-19 Drugs Market Size by Type 6.2.1 North America COVID-19 Drugs Market Size by Type (2018-2023) 6.2.2 North America COVID-19 Drugs Market Size by Type (2024-2029) 6.2.3 North America COVID-19 Drugs Market Share by Type (2018-2029) 6.3 North America COVID-19 Drugs Market Size by Application 6.3.1 North America COVID-19 Drugs Market Size by Application (2018-2023) 6.3.2 North America COVID-19 Drugs Market Size by Application (2024-2029) 6.3.3 North America COVID-19 Drugs Market Share by Application (2018-2029) 6.4 North America COVID-19 Drugs Market Size by Country 6.4.1 North America COVID-19 Drugs Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America COVID-19 Drugs Market Size by Country (2018-2023) 6.4.3 North America COVID-19 Drugs Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe COVID-19 Drugs Market Size (2018-2029) 7.2 Europe COVID-19 Drugs Market Size by Type 7.2.1 Europe COVID-19 Drugs Market Size by Type (2018-2023) 7.2.2 Europe COVID-19 Drugs Market Size by Type (2024-2029) 7.2.3 Europe COVID-19 Drugs Market Share by Type (2018-2029) 7.3 Europe COVID-19 Drugs Market Size by Application 7.3.1 Europe COVID-19 Drugs Market Size by Application (2018-2023) 7.3.2 Europe COVID-19 Drugs Market Size by Application (2024-2029) 7.3.3 Europe COVID-19 Drugs Market Share by Application (2018-2029) 7.4 Europe COVID-19 Drugs Market Size by Country 7.4.1 Europe COVID-19 Drugs Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe COVID-19 Drugs Market Size by Country (2018-2023) 7.4.3 Europe COVID-19 Drugs Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China COVID-19 Drugs Market Size (2018-2029) 8.2 China COVID-19 Drugs Market Size by Type 8.2.1 China COVID-19 Drugs Market Size by Type (2018-2023) 8.2.2 China COVID-19 Drugs Market Size by Type (2024-2029) 8.2.3 China COVID-19 Drugs Market Share by Type (2018-2029) 8.3 China COVID-19 Drugs Market Size by Application 8.3.1 China COVID-19 Drugs Market Size by Application (2018-2023) 8.3.2 China COVID-19 Drugs Market Size by Application (2024-2029) 8.3.3 China COVID-19 Drugs Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia COVID-19 Drugs Market Size (2018-2029) 9.2 Asia COVID-19 Drugs Market Size by Type 9.2.1 Asia COVID-19 Drugs Market Size by Type (2018-2023) 9.2.2 Asia COVID-19 Drugs Market Size by Type (2024-2029) 9.2.3 Asia COVID-19 Drugs Market Share by Type (2018-2029) 9.3 Asia COVID-19 Drugs Market Size by Application 9.3.1 Asia COVID-19 Drugs Market Size by Application (2018-2023) 9.3.2 Asia COVID-19 Drugs Market Size by Application (2024-2029) 9.3.3 Asia COVID-19 Drugs Market Share by Application (2018-2029) 9.4 Asia COVID-19 Drugs Market Size by Region 9.4.1 Asia COVID-19 Drugs Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia COVID-19 Drugs Market Size by Region (2018-2023) 9.4.3 Asia COVID-19 Drugs Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type 10.2.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application 10.3.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country 10.4.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi COVID-19 Drugs Introduction 11.1.4 Sanofi Revenue in COVID-19 Drugs Business (2018-2023) 11.1.5 Sanofi Recent Developments 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis COVID-19 Drugs Introduction 11.2.4 Novartis Revenue in COVID-19 Drugs Business (2018-2023) 11.2.5 Novartis Recent Developments 11.3 Shanghai Zhongxisanwei 11.3.1 Shanghai Zhongxisanwei Company Details 11.3.2 Shanghai Zhongxisanwei Business Overview 11.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Introduction 11.3.4 Shanghai Zhongxisanwei Revenue in COVID-19 Drugs Business (2018-2023) 11.3.5 Shanghai Zhongxisanwei Recent Developments 11.4 Teva 11.4.1 Teva Company Details 11.4.2 Teva Business Overview 11.4.3 Teva COVID-19 Drugs Introduction 11.4.4 Teva Revenue in COVID-19 Drugs Business (2018-2023) 11.4.5 Teva Recent Developments 11.5 Zydus Cadila 11.5.1 Zydus Cadila Company Details 11.5.2 Zydus Cadila Business Overview 11.5.3 Zydus Cadila COVID-19 Drugs Introduction 11.5.4 Zydus Cadila Revenue in COVID-19 Drugs Business (2018-2023) 11.5.5 Zydus Cadila Recent Developments 11.6 Mylan 11.6.1 Mylan Company Details 11.6.2 Mylan Business Overview 11.6.3 Mylan COVID-19 Drugs Introduction 11.6.4 Mylan Revenue in COVID-19 Drugs Business (2018-2023) 11.6.5 Mylan Recent Developments 11.7 Apotex 11.7.1 Apotex Company Details 11.7.2 Apotex Business Overview 11.7.3 Apotex COVID-19 Drugs Introduction 11.7.4 Apotex Revenue in COVID-19 Drugs Business (2018-2023) 11.7.5 Apotex Recent Developments 11.8 Advanz Pharma 11.8.1 Advanz Pharma Company Details 11.8.2 Advanz Pharma Business Overview 11.8.3 Advanz Pharma COVID-19 Drugs Introduction 11.8.4 Advanz Pharma Revenue in COVID-19 Drugs Business (2018-2023) 11.8.5 Advanz Pharma Recent Developments 11.9 Sun Pharma 11.9.1 Sun Pharma Company Details 11.9.2 Sun Pharma Business Overview 11.9.3 Sun Pharma COVID-19 Drugs Introduction 11.9.4 Sun Pharma Revenue in COVID-19 Drugs Business (2018-2023) 11.9.5 Sun Pharma Recent Developments 11.10 Kyung Poong 11.10.1 Kyung Poong Company Details 11.10.2 Kyung Poong Business Overview 11.10.3 Kyung Poong COVID-19 Drugs Introduction 11.10.4 Kyung Poong Revenue in COVID-19 Drugs Business (2018-2023) 11.10.5 Kyung Poong Recent Developments 11.11 Ipca Laboratories 11.11.1 Ipca Laboratories Company Details 11.11.2 Ipca Laboratories Business Overview 11.11.3 Ipca Laboratories COVID-19 Drugs Introduction 11.11.4 Ipca Laboratories Revenue in COVID-19 Drugs Business (2018-2023) 11.11.5 Ipca Laboratories Recent Developments 11.12 Hanlim Pharmaceutical 11.12.1 Hanlim Pharmaceutical Company Details 11.12.2 Hanlim Pharmaceutical Business Overview 11.12.3 Hanlim Pharmaceutical COVID-19 Drugs Introduction 11.12.4 Hanlim Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) 11.12.5 Hanlim Pharmaceutical Recent Developments 11.13 Bristol Laboratories 11.13.1 Bristol Laboratories Company Details 11.13.2 Bristol Laboratories Business Overview 11.13.3 Bristol Laboratories COVID-19 Drugs Introduction 11.13.4 Bristol Laboratories Revenue in COVID-19 Drugs Business (2018-2023) 11.13.5 Bristol Laboratories Recent Developments 11.14 Bayer 11.14.1 Bayer Company Details 11.14.2 Bayer Business Overview 11.14.3 Bayer COVID-19 Drugs Introduction 11.14.4 Bayer Revenue in COVID-19 Drugs Business (2018-2023) 11.14.5 Bayer Recent Developments 11.15 Rising Pharmaceutical 11.15.1 Rising Pharmaceutical Company Details 11.15.2 Rising Pharmaceutical Business Overview 11.15.3 Rising Pharmaceutical COVID-19 Drugs Introduction 11.15.4 Rising Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) 11.15.5 Rising Pharmaceutical Recent Developments 11.16 Shanghai Pharma 11.16.1 Shanghai Pharma Company Details 11.16.2 Shanghai Pharma Business Overview 11.16.3 Shanghai Pharma COVID-19 Drugs Introduction 11.16.4 Shanghai Pharma Revenue in COVID-19 Drugs Business (2018-2023) 11.16.5 Shanghai Pharma Recent Developments 11.17 Sichuan Sunny Hope 11.17.1 Sichuan Sunny Hope Company Details 11.17.2 Sichuan Sunny Hope Business Overview 11.17.3 Sichuan Sunny Hope COVID-19 Drugs Introduction 11.17.4 Sichuan Sunny Hope Revenue in COVID-19 Drugs Business (2018-2023) 11.17.5 Sichuan Sunny Hope Recent Developments 11.18 Guangzhou Baiyunshan Guanghua Pharmaceutical 11.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details 11.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview 11.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Introduction 11.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) 11.18.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments 11.19 CSPC Group 11.19.1 CSPC Group Company Details 11.19.2 CSPC Group Business Overview 11.19.3 CSPC Group COVID-19 Drugs Introduction 11.19.4 CSPC Group Revenue in COVID-19 Drugs Business (2018-2023) 11.19.5 CSPC Group Recent Developments 11.20 KPC Group 11.20.1 KPC Group Company Details 11.20.2 KPC Group Business Overview 11.20.3 KPC Group COVID-19 Drugs Introduction 11.20.4 KPC Group Revenue in COVID-19 Drugs Business (2018-2023) 11.20.5 KPC Group Recent Developments 11.21 Jinghua Pharmaceutical Group 11.21.1 Jinghua Pharmaceutical Group Company Details 11.21.2 Jinghua Pharmaceutical Group Business Overview 11.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Introduction 11.21.4 Jinghua Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023) 11.21.5 Jinghua Pharmaceutical Group Recent Developments 11.22 Zhongsheng Pharma 11.22.1 Zhongsheng Pharma Company Details 11.22.2 Zhongsheng Pharma Business Overview 11.22.3 Zhongsheng Pharma COVID-19 Drugs Introduction 11.22.4 Zhongsheng Pharma Revenue in COVID-19 Drugs Business (2018-2023) 11.22.5 Zhongsheng Pharma Recent Developments 11.23 North China Pharmaceutical Group 11.23.1 North China Pharmaceutical Group Company Details 11.23.2 North China Pharmaceutical Group Business Overview 11.23.3 North China Pharmaceutical Group COVID-19 Drugs Introduction 11.23.4 North China Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023) 11.23.5 North China Pharmaceutical Group Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global COVID-19 Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029 Table 2. Key Players of Tablet Table 3. Key Players of Injection Table 4. Global COVID-19 Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029 Table 5. Global COVID-19 Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global COVID-19 Drugs Market Size by Region (2018-2023) & (US$ Million) Table 7. Global COVID-19 Drugs Market Share by Region (2018-2023) Table 8. Global COVID-19 Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global COVID-19 Drugs Market Share by Region (2024-2029) Table 10. COVID-19 Drugs Market Trends Table 11. COVID-19 Drugs Market Drivers Table 12. COVID-19 Drugs Market Challenges Table 13. COVID-19 Drugs Market Restraints Table 14. Global COVID-19 Drugs Revenue by Players (2018-2023) & (US$ Million) Table 15. Global COVID-19 Drugs Revenue Share by Players (2018-2023) Table 16. Global Top COVID-19 Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Drugs as of 2022) Table 17. Global COVID-19 Drugs Industry Ranking 2021 VS 2022 VS 2023 Table 18. Global 5 Largest Players Market Share by COVID-19 Drugs Revenue (CR5 and HHI) & (2018-2023) Table 19. Global Key Players of COVID-19 Drugs, Headquarters and Area Served Table 20. Global Key Players of COVID-19 Drugs, Product and Application Table 21. Global Key Players of COVID-19 Drugs, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million) Table 24. Global COVID-19 Drugs Revenue Market Share by Type (2018-2023) Table 25. Global COVID-19 Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global COVID-19 Drugs Revenue Market Share by Type (2024-2029) Table 27. Global COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million) Table 28. Global COVID-19 Drugs Revenue Share by Application (2018-2023) Table 29. Global COVID-19 Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global COVID-19 Drugs Revenue Share by Application (2024-2029) Table 31. North America COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million) Table 32. North America COVID-19 Drugs Market Size by Type (2024-2029) & (US$ Million) Table 33. North America COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million) Table 34. North America COVID-19 Drugs Market Size by Application (2024-2029) & (US$ Million) Table 35. North America COVID-19 Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. North America COVID-19 Drugs Market Size by Country (2018-2023) & (US$ Million) Table 37. North America COVID-19 Drugs Market Size by Country (2024-2029) & (US$ Million) Table 38. Europe COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million) Table 39. Europe COVID-19 Drugs Market Size by Type (2024-2029) & (US$ Million) Table 40. Europe COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million) Table 41. Europe COVID-19 Drugs Market Size by Application (2024-2029) & (US$ Million) Table 42. Europe COVID-19 Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Europe COVID-19 Drugs Market Size by Country (2018-2023) & (US$ Million) Table 44. Europe COVID-19 Drugs Market Size by Country (2024-2029) & (US$ Million) Table 45. China COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million) Table 46. China COVID-19 Drugs Market Size by Type (2024-2029) & (US$ Million) Table 47. China COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million) Table 48. China COVID-19 Drugs Market Size by Application (2024-2029) & (US$ Million) Table 49. Asia COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million) Table 50. Asia COVID-19 Drugs Market Size by Type (2024-2029) & (US$ Million) Table 51. Asia COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million) Table 52. Asia COVID-19 Drugs Market Size by Application (2024-2029) & (US$ Million) Table 53. Asia COVID-19 Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029 Table 54. Asia COVID-19 Drugs Market Size by Region (2018-2023) & (US$ Million) Table 55. Asia COVID-19 Drugs Market Size by Region (2024-2029) & (US$ Million) Table 56. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million) Table 57. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2024-2029) & (US$ Million) Table 58. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million) Table 59. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2024-2029) & (US$ Million) Table 60. Middle East, Africa, and Latin America COVID-19 Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029 Table 61. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2018-2023) & (US$ Million) Table 62. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2024-2029) & (US$ Million) Table 63. Sanofi Company Details Table 64. Sanofi Business Overview Table 65. Sanofi COVID-19 Drugs Product Table 66. Sanofi Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 67. Sanofi Recent Developments Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis COVID-19 Drugs Product Table 71. Novartis Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 72. Novartis Recent Developments Table 73. Shanghai Zhongxisanwei Company Details Table 74. Shanghai Zhongxisanwei Business Overview Table 75. Shanghai Zhongxisanwei COVID-19 Drugs Product Table 76. Shanghai Zhongxisanwei Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 77. Shanghai Zhongxisanwei Recent Developments Table 78. Teva Company Details Table 79. Teva Business Overview Table 80. Teva COVID-19 Drugs Product Table 81. Teva Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 82. Teva Recent Developments Table 83. Zydus Cadila Company Details Table 84. Zydus Cadila Business Overview Table 85. Zydus Cadila COVID-19 Drugs Product Table 86. Zydus Cadila Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 87. Zydus Cadila Recent Developments Table 88. Mylan Company Details Table 89. Mylan Business Overview Table 90. Mylan COVID-19 Drugs Product Table 91. Mylan Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 92. Mylan Recent Developments Table 93. Apotex Company Details Table 94. Apotex Business Overview Table 95. Apotex COVID-19 Drugs Product Table 96. Apotex Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 97. Apotex Recent Developments Table 98. Advanz Pharma Company Details Table 99. Advanz Pharma Business Overview Table 100. Advanz Pharma COVID-19 Drugs Product Table 101. Advanz Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 102. Advanz Pharma Recent Developments Table 103. Sun Pharma Company Details Table 104. Sun Pharma Business Overview Table 105. Sun Pharma COVID-19 Drugs Product Table 106. Sun Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 107. Sun Pharma Recent Developments Table 108. Kyung Poong Company Details Table 109. Kyung Poong Business Overview Table 110. Kyung Poong COVID-19 Drugs Product Table 111. Kyung Poong Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 112. Kyung Poong Recent Developments Table 113. Ipca Laboratories Company Details Table 114. Ipca Laboratories Business Overview Table 115. Ipca Laboratories COVID-19 Drugs Product Table 116. Ipca Laboratories Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 117. Ipca Laboratories Recent Developments Table 118. Hanlim Pharmaceutical Company Details Table 119. Hanlim Pharmaceutical Business Overview Table 120. Hanlim Pharmaceutical COVID-19 Drugs Product Table 121. Hanlim Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 122. Hanlim Pharmaceutical Recent Developments Table 123. Bristol Laboratories Company Details Table 124. Bristol Laboratories Business Overview Table 125. Bristol Laboratories COVID-19 Drugs Product Table 126. Bristol Laboratories Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 127. Bristol Laboratories Recent Developments Table 128. Bayer Company Details Table 129. Bayer Business Overview Table 130. Bayer COVID-19 Drugs Product Table 131. Bayer Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 132. Bayer Recent Developments Table 133. Rising Pharmaceutical Company Details Table 134. Rising Pharmaceutical Business Overview Table 135. Rising Pharmaceutical COVID-19 Drugs Product Table 136. Rising Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 137. Rising Pharmaceutical Recent Developments Table 138. Shanghai Pharma Company Details Table 139. Shanghai Pharma Business Overview Table 140. Shanghai Pharma COVID-19 Drugs Product Table 141. Shanghai Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 142. Shanghai Pharma Recent Developments Table 143. Sichuan Sunny Hope Company Details Table 144. Sichuan Sunny Hope Business Overview Table 145. Sichuan Sunny Hope COVID-19 Drugs Product Table 146. Sichuan Sunny Hope Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 147. Sichuan Sunny Hope Recent Developments Table 148. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details Table 149. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 150. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product Table 151. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 152. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments Table 153. CSPC Group Company Details Table 154. CSPC Group Business Overview Table 155. CSPC Group COVID-19 Drugs Product Table 156. CSPC Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 157. CSPC Group Recent Developments Table 158. KPC Group Company Details Table 159. KPC Group Business Overview Table 160. KPC Group COVID-19 Drugs Product Table 161. KPC Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 162. KPC Group Recent Developments Table 163. Jinghua Pharmaceutical Group Company Details Table 164. Jinghua Pharmaceutical Group Business Overview Table 165. Jinghua Pharmaceutical Group COVID-19 Drugs Product Table 166. Jinghua Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 167. Jinghua Pharmaceutical Group Recent Developments Table 168. Zhongsheng Pharma Company Details Table 169. Zhongsheng Pharma Business Overview Table 170. Zhongsheng Pharma COVID-19 Drugs Product Table 171. Zhongsheng Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 172. Zhongsheng Pharma Recent Developments Table 173. North China Pharmaceutical Group Company Details Table 174. North China Pharmaceutical Group Business Overview Table 175. North China Pharmaceutical Group COVID-19 Drugs Product Table 176. North China Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million) Table 177. North China Pharmaceutical Group Recent Developments Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Global COVID-19 Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) Figure 2. Global COVID-19 Drugs Market Share by Type: 2022 VS 2029 Figure 3. Tablet Features Figure 4. Injection Features Figure 5. Global COVID-19 Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) Figure 6. Global COVID-19 Drugs Market Share by Application: 2022 VS 2029 Figure 7. Mild Symptom Patient Case Studies Figure 8. Critically Ill Patient Case Studies Figure 9. COVID-19 Drugs Report Years Considered Figure 10. Global COVID-19 Drugs Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 11. Global COVID-19 Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global COVID-19 Drugs Market Share by Region: 2022 VS 2029 Figure 13. Global COVID-19 Drugs Market Share by Players in 2022 Figure 14. Global Top COVID-19 Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Drugs as of 2022) Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Drugs Revenue in 2022 Figure 16. North America COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 17. North America COVID-19 Drugs Market Share by Type (2018-2029) Figure 18. North America COVID-19 Drugs Market Share by Application (2018-2029) Figure 19. North America COVID-19 Drugs Market Share by Country (2018-2029) Figure 20. United States COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Canada COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe COVID-19 Drugs Market Size YoY (2018-2029) & (US$ Million) Figure 23. Europe COVID-19 Drugs Market Share by Type (2018-2029) Figure 24. Europe COVID-19 Drugs Market Share by Application (2018-2029) Figure 25. Europe COVID-19 Drugs Market Share by Country (2018-2029) Figure 26. Germany COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. China COVID-19 Drugs Market Size YoY (2018-2029) & (US$ Million) Figure 33. China COVID-19 Drugs Market Share by Type (2018-2029) Figure 34. China COVID-19 Drugs Market Share by Application (2018-2029) Figure 35. Asia COVID-19 Drugs Market Size YoY (2018-2029) & (US$ Million) Figure 36. Asia COVID-19 Drugs Market Share by Type (2018-2029) Figure 37. Asia COVID-19 Drugs Market Share by Application (2018-2029) Figure 38. Asia COVID-19 Drugs Market Share by Region (2018-2029) Figure 39. Japan COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. South Korea COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. China Taiwan COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Southeast Asia COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. India COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Australia COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East, Africa, and Latin America COVID-19 Drugs Market Size YoY (2018-2029) & (US$ Million) Figure 46. Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Type (2018-2029) Figure 47. Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Application (2018-2029) Figure 48. Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Country (2018-2029) Figure 49. Brazil COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Mexico COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 51. Turkey COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 52. Saudi Arabia COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 53. Israel COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 54. GCC Countries COVID-19 Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 55. Sanofi Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 56. Novartis Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 57. Shanghai Zhongxisanwei Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 58. Teva Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 59. Zydus Cadila Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 60. Mylan Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 61. Apotex Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 62. Advanz Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 63. Sun Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 64. Kyung Poong Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 65. Ipca Laboratories Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 66. Hanlim Pharmaceutical Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 67. Bristol Laboratories Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 68. Bayer Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 69. Rising Pharmaceutical Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 70. Shanghai Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 71. Sichuan Sunny Hope Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 72. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 73. CSPC Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 74. KPC Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 75. Jinghua Pharmaceutical Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 76. Zhongsheng Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 77. North China Pharmaceutical Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Sanofi Novartis Shanghai Zhongxisanwei Teva Zydus Cadila Mylan Apotex Advanz Pharma Sun Pharma Kyung Poong Ipca Laboratories Hanlim Pharmaceutical Bristol Laboratories Bayer Rising Pharmaceutical Shanghai Pharma Sichuan Sunny Hope Guangzhou Baiyunshan Guanghua Pharmaceutical CSPC Group KPC Group Jinghua Pharmaceutical Group Zhongsheng Pharma North China Pharmaceutical Group